Inspire Medical Systems, Inc. - Common Stock, $0.001 par value per share (INSP)

CUSIP: 457730109

Q3 2018 13F Holders as of 30 Sep 2018

Holder snapshot 6 signals
Share change
-194,247
SEC-reported price per share
$42.08
Indexed holders
85
Value change
-$2,907,456
Number of buys
52
Number of sells
39
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
29,073,952

Security key

457730109

Report period

Q3 2018

Indexed institutions

85

Top holders

10

Ownership snapshot

Top reported holders of INSP - Inspire Medical Systems, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
30 Jun 2018
13F Highest disclosed value: $87,161,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $87.16M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
ORBIMED ADVISORS LLC $87.16M
MILLENNIUM MANAGEMENT LLC $26.75M
TimesSquare Capital Management, LLC $23.53M
FRANKLIN TEMPLETON INC $20.63M
BlackRock Finance, Inc. $19.62M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$87,161,000
2,444,221 shares
— 30 Jun 2018
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$26,752,000
750,190 shares
— 30 Jun 2018
TimesSquare Capital Management, LLC
13F
Company
13F
—
denominator unverified
$23,532,000
659,900 shares
— 30 Jun 2018
FRANKLIN TEMPLETON INC
13F
Company
13F
—
denominator unverified
$20,627,000
578,446 shares
— 30 Jun 2018
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$19,624,000
550,305 shares
— 30 Jun 2018
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$12,718,000
356,652 shares
— 30 Jun 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
85
Shares
9,259,018
Indexed holders
85
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 indexed holders
75
Q3 2018 indexed holders
85
Indexed holder difference
10
Investor Q2 2018 Shares Q3 2018 Shares Share Diff Share Chg % Q2 2018 value Q3 2018 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .